Healthpoint Biotherapeutics, a Fort Worth-based company focused on skin and wound care, said Wednesday it will spend $60 million on its research and manufacturing facility here in the next few years to support development of new treatments. Healthpoint said it expects to hire 31 new workers this year and would add another 20 over time. The first phase should be in operation by year's end. It will include 25,000 square feet of manufacturing infrastructure, labs and clean room space "for the production of cell-based therapies." The company's lead effort, now in clinical trials, applies living human cells to ulcers that develop in patients with poorly functioning leg veins. "We are very pleased to be embarking on this important and innovative initiative at our headquarters here in Fort Worth," said President Travis Baugh.
-- Jim Fuquay